The University of Chicago Header Logo

Jessica Donington

Concepts (404)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
52
2023
1018
13.180
Why?
Lung Neoplasms
75
2023
2168
12.460
Why?
Pneumonectomy
22
2022
191
6.510
Why?
Thoracic Surgery
8
2022
40
3.480
Why?
Neoplasm Staging
37
2023
1883
3.330
Why?
Osteopontin
6
2013
48
2.130
Why?
Radiosurgery
9
2021
262
1.880
Why?
Physicians, Women
5
2022
50
1.720
Why?
Thoracic Surgical Procedures
4
2022
42
1.710
Why?
Surgeons
5
2021
190
1.630
Why?
Specialties, Surgical
2
2021
59
1.560
Why?
Humans
125
2023
80897
1.510
Why?
Thoracic Surgery, Video-Assisted
6
2022
27
1.480
Why?
Adenocarcinoma
11
2016
1125
1.390
Why?
Early Detection of Cancer
4
2022
350
1.320
Why?
Pleural Neoplasms
11
2016
184
1.250
Why?
Small Cell Lung Carcinoma
4
2023
94
1.210
Why?
Mesothelioma
13
2016
289
1.200
Why?
Esophagectomy
5
2009
74
1.190
Why?
Disease Management
3
2019
317
0.950
Why?
Catheter Ablation
6
2015
216
0.950
Why?
Jehovah's Witnesses
1
2022
18
0.930
Why?
Tomography, X-Ray Computed
11
2020
2440
0.930
Why?
Neoadjuvant Therapy
6
2022
274
0.910
Why?
Neoplasm Recurrence, Local
11
2023
1219
0.880
Why?
Biomarkers, Tumor
5
2021
1409
0.850
Why?
Symptom Assessment
1
2020
54
0.800
Why?
Esophageal Neoplasms
4
2009
304
0.790
Why?
Antibody Formation
1
2020
169
0.790
Why?
Antibodies, Viral
2
2021
292
0.770
Why?
Combined Modality Therapy
11
2022
1613
0.760
Why?
Immunotherapy
5
2022
570
0.750
Why?
Robotic Surgical Procedures
2
2022
225
0.740
Why?
Surgical Flaps
3
2017
245
0.740
Why?
Chemotherapy, Adjuvant
5
2022
446
0.740
Why?
Societies, Medical
3
2020
564
0.740
Why?
Mass Screening
3
2022
597
0.730
Why?
Carcinoma, Squamous Cell
5
2016
1045
0.710
Why?
Neoplasms, Second Primary
5
2016
247
0.680
Why?
Radium
3
2021
6
0.640
Why?
Probability
1
2017
344
0.620
Why?
Skin Ulcer
1
2016
25
0.620
Why?
Salvage Therapy
2
2017
227
0.620
Why?
Female
43
2022
42456
0.600
Why?
Treatment Outcome
13
2022
7492
0.600
Why?
Hyaluronan Receptors
2
2013
38
0.580
Why?
Frozen Sections
1
2015
47
0.580
Why?
Skin Transplantation
1
2016
170
0.570
Why?
Prognosis
16
2021
3544
0.560
Why?
Male
38
2021
39412
0.560
Why?
Middle Aged
31
2021
23961
0.560
Why?
Esophagus
2
2006
101
0.550
Why?
Monitoring, Intraoperative
1
2015
107
0.550
Why?
United States
13
2022
6169
0.520
Why?
Fluorodeoxyglucose F18
3
2012
124
0.520
Why?
Aged
26
2022
17475
0.520
Why?
Radiopharmaceuticals
3
2012
159
0.510
Why?
Pancoast Syndrome
1
2013
2
0.510
Why?
Fas Ligand Protein
1
2013
49
0.480
Why?
Positron-Emission Tomography
5
2013
277
0.480
Why?
Adult
27
2022
24636
0.460
Why?
Fluorine Radioisotopes
1
2012
13
0.450
Why?
Retrospective Studies
13
2023
7560
0.450
Why?
Skin Neoplasms
1
2016
512
0.450
Why?
Radiation Injuries
2
2010
154
0.440
Why?
Cyclooxygenase 2
1
2012
98
0.440
Why?
Multimodal Imaging
1
2012
102
0.420
Why?
Neurosurgical Procedures
1
2013
204
0.420
Why?
Bronchogenic Cyst
1
2010
5
0.420
Why?
Thoracic Wall
1
2010
22
0.410
Why?
Soft Tissue Infections
1
2010
22
0.410
Why?
Thoracic Diseases
1
2010
25
0.410
Why?
Clinical Trials as Topic
4
2020
1142
0.390
Why?
Risk Assessment
7
2022
2171
0.380
Why?
Simulation Training
2
2021
83
0.380
Why?
Radiotherapy, Adjuvant
3
2022
285
0.370
Why?
Survival Analysis
4
2019
1512
0.370
Why?
Education, Medical, Graduate
3
2020
344
0.370
Why?
Health Status Disparities
1
2011
155
0.350
Why?
Neoplasm Proteins
1
2012
530
0.340
Why?
Aged, 80 and over
15
2021
6214
0.320
Why?
Survival Rate
9
2021
1811
0.310
Why?
Healthcare Disparities
1
2011
335
0.300
Why?
Dumping Syndrome
1
2006
5
0.300
Why?
Gastric Emptying
1
2006
22
0.300
Why?
Antineoplastic Agents
5
2020
2274
0.290
Why?
Protein Kinase Inhibitors
2
2022
558
0.290
Why?
Stomach
1
2006
108
0.280
Why?
Wounds, Nonpenetrating
1
2006
82
0.280
Why?
Esophageal Diseases
1
2005
25
0.280
Why?
Transcription Factors
1
2013
1485
0.280
Why?
Deglutition Disorders
1
2006
99
0.270
Why?
Patient Selection
3
2020
661
0.270
Why?
Patient Care Management
2
2020
31
0.270
Why?
Pneumonia, Viral
2
2020
302
0.270
Why?
Coronavirus Infections
2
2020
286
0.270
Why?
Consensus
3
2021
296
0.260
Why?
Intubation, Intratracheal
1
2006
137
0.260
Why?
General Surgery
1
2007
215
0.260
Why?
Risk Factors
5
2022
5137
0.260
Why?
Gastroesophageal Reflux
1
2006
111
0.260
Why?
Computer Simulation
3
2021
1045
0.260
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2011
2346
0.250
Why?
Antibodies, Neutralizing
2
2021
101
0.240
Why?
Hamartoma
1
2003
31
0.240
Why?
Negative-Pressure Wound Therapy
2
2014
10
0.240
Why?
Lymphatic Metastasis
4
2010
466
0.240
Why?
Medical Oncology
1
2007
331
0.240
Why?
Chylous Ascites
1
2022
6
0.230
Why?
Carcinoma, Bronchogenic
1
2002
30
0.230
Why?
Chylothorax
1
2022
7
0.230
Why?
Lung
4
2022
1092
0.230
Why?
Neoplasm Metastasis
3
2019
1036
0.220
Why?
Loss of Function Mutation
1
2021
39
0.210
Why?
ErbB Receptors
2
2022
473
0.210
Why?
Funnel Chest
1
2021
5
0.210
Why?
Pneumothorax
2
2020
49
0.210
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
103
0.210
Why?
Lung Diseases
1
2003
255
0.210
Why?
Spike Glycoprotein, Coronavirus
1
2021
35
0.210
Why?
Chemoradiotherapy
2
2020
296
0.210
Why?
Immunization, Passive
1
2020
69
0.200
Why?
SEER Program
2
2011
180
0.200
Why?
Pandemics
3
2021
628
0.200
Why?
Lung Transplantation
1
2022
168
0.200
Why?
Critical Pathways
1
2020
32
0.190
Why?
Betacoronavirus
2
2020
245
0.190
Why?
Case-Control Studies
4
2013
1742
0.190
Why?
Sexual Harassment
1
2019
8
0.190
Why?
Riots
1
2019
1
0.190
Why?
Clinical Decision-Making
2
2019
243
0.190
Why?
Career Choice
1
2021
136
0.190
Why?
Protein Isoforms
2
2010
260
0.180
Why?
Drainage
1
2020
141
0.180
Why?
Sexism
1
2019
39
0.180
Why?
Nontuberculous Mycobacteria
1
2018
9
0.180
Why?
Randomized Controlled Trials as Topic
2
2020
809
0.180
Why?
Mycobacterium Infections, Nontuberculous
1
2018
24
0.180
Why?
Immunoglobulin G
1
2020
444
0.170
Why?
Thoracotomy
1
2018
55
0.170
Why?
Diagnosis, Differential
4
2013
1509
0.170
Why?
Cohort Studies
5
2012
2583
0.170
Why?
Periodicals as Topic
1
2020
161
0.170
Why?
Drug Resistance, Neoplasm
1
2021
561
0.170
Why?
Respiratory System
1
2018
113
0.170
Why?
Cost-Benefit Analysis
1
2020
422
0.160
Why?
Wound Closure Techniques
1
2017
12
0.160
Why?
Safety-net Providers
1
2018
36
0.160
Why?
Consolidation Chemotherapy
1
2017
21
0.160
Why?
Evidence-Based Medicine
2
2017
418
0.160
Why?
Thoracic Neoplasms
1
2017
60
0.160
Why?
Prosthesis-Related Infections
1
2017
56
0.150
Why?
Lymph Nodes
2
2011
509
0.150
Why?
Meta-Analysis as Topic
4
2016
85
0.150
Why?
Cell Proliferation
2
2013
1539
0.150
Why?
Asbestos
2
2012
22
0.140
Why?
National Cancer Institute (U.S.)
1
2015
68
0.140
Why?
Defibrillators, Implantable
1
2017
128
0.140
Why?
Surgical Wound Infection
1
2017
172
0.140
Why?
Biopsy
2
2016
1126
0.140
Why?
Forecasting
1
2016
305
0.140
Why?
Apoptosis
2
2013
1645
0.140
Why?
Subcutaneous Emphysema
1
2014
6
0.140
Why?
Photochemotherapy
1
1995
94
0.140
Why?
Simian virus 40
4
1998
35
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
861
0.130
Why?
Area Under Curve
2
2012
326
0.130
Why?
Liver Transplantation
1
2022
1220
0.130
Why?
Radiography
2
2014
790
0.130
Why?
Receptor, EphB2
1
2013
2
0.130
Why?
Neoplasm Invasiveness
2
2013
516
0.130
Why?
Microbiota
1
2018
332
0.120
Why?
Peritoneum
1
2013
47
0.120
Why?
Neoplasm, Residual
2
2019
144
0.120
Why?
Snail Family Transcription Factors
1
2013
24
0.120
Why?
Operative Time
1
2013
111
0.120
Why?
Surveys and Questionnaires
1
2021
2284
0.120
Why?
Clinical Protocols
1
2013
153
0.120
Why?
ROC Curve
2
2012
734
0.120
Why?
Time-to-Treatment
1
2013
75
0.120
Why?
Blotting, Western
2
2013
772
0.120
Why?
Epithelium
1
2013
309
0.110
Why?
Pain Management
1
2013
119
0.110
Why?
Postoperative Complications
2
2020
2064
0.110
Why?
Cytokines
3
2022
748
0.110
Why?
Clinical Trials, Phase III as Topic
2
2007
158
0.110
Why?
Extracellular Matrix Proteins
1
2012
121
0.110
Why?
Biomarkers
2
2016
1603
0.110
Why?
Occupational Exposure
1
2012
75
0.110
Why?
Solitary Pulmonary Nodule
1
2013
136
0.110
Why?
Job Satisfaction
1
2012
71
0.110
Why?
Perfusion
2
2022
186
0.110
Why?
Palliative Care
1
2013
234
0.110
Why?
Young Adult
5
2021
5725
0.110
Why?
Radiotherapy, Computer-Assisted
1
2011
25
0.110
Why?
Carcinoma, Large Cell
1
2011
39
0.100
Why?
Sternoclavicular Joint
1
2010
2
0.100
Why?
Pulmonary Surgical Procedures
1
2010
8
0.100
Why?
Colony-Forming Units Assay
1
2010
40
0.100
Why?
Cranial Irradiation
2
2020
35
0.100
Why?
Mutation
1
2022
3792
0.100
Why?
Ribonucleases
1
2011
92
0.100
Why?
Debridement
1
2010
56
0.100
Why?
Computer-Assisted Instruction
1
2011
43
0.100
Why?
Functional Laterality
1
2011
193
0.100
Why?
Antibodies, Monoclonal
1
2017
1363
0.100
Why?
Models, Anatomic
1
2011
89
0.100
Why?
Cell Movement
2
2013
735
0.100
Why?
Epithelial-Mesenchymal Transition
1
2010
61
0.100
Why?
Models, Cardiovascular
1
2011
96
0.100
Why?
Tumor Cells, Cultured
3
2009
1031
0.100
Why?
Cell Line, Tumor
3
2011
2324
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2010
680
0.100
Why?
Tumor Burden
2
2011
274
0.100
Why?
Necrosis
1
2010
189
0.100
Why?
Internship and Residency
1
2019
928
0.100
Why?
Joint Diseases
1
2010
47
0.100
Why?
Opioid-Related Disorders
1
2012
133
0.100
Why?
Follow-Up Studies
4
2021
3533
0.100
Why?
Pain, Postoperative
1
2012
218
0.100
Why?
Prospective Studies
5
2018
3926
0.100
Why?
Tracheal Neoplasms
1
2009
8
0.100
Why?
Glomus Tumor
1
2009
8
0.100
Why?
Chest Pain
1
2009
36
0.090
Why?
Sarcoidosis
1
2010
67
0.090
Why?
Tuberculosis
1
2010
99
0.090
Why?
Minimally Invasive Surgical Procedures
1
2011
214
0.090
Why?
Endosonography
1
2010
92
0.090
Why?
Cell Adhesion
1
2010
413
0.090
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
373
0.090
Why?
Length of Stay
2
2020
656
0.090
Why?
Mediastinal Neoplasms
2
2005
44
0.090
Why?
MicroRNAs
2
2011
511
0.090
Why?
Time Factors
3
2012
5094
0.090
Why?
RNA, Messenger
2
2013
1931
0.090
Why?
Microwaves
1
2008
25
0.080
Why?
Wound Healing
1
2010
336
0.080
Why?
Analgesics, Opioid
1
2012
370
0.080
Why?
Radiation Oncologists
2
2018
13
0.080
Why?
NF-kappa B
1
2011
422
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
371
0.080
Why?
Chest Tubes
2
2020
22
0.080
Why?
Sex Factors
1
2011
1021
0.080
Why?
DNA, Viral
2
1998
264
0.080
Why?
Receptor, IGF Type 1
2
1998
44
0.080
Why?
Neovascularization, Pathologic
1
2009
336
0.080
Why?
Gene Expression Profiling
2
2010
1328
0.080
Why?
Pulmonary Ventilation
1
2006
32
0.080
Why?
Diagnostic Imaging
1
2011
450
0.080
Why?
Cognition
1
2011
500
0.080
Why?
Sialoglycoproteins
1
2006
32
0.070
Why?
Carbonic Anhydrases
1
2006
12
0.070
Why?
Disease-Free Survival
2
2011
1183
0.070
Why?
Sex Distribution
1
2006
170
0.070
Why?
Mediastinoscopy
1
2005
5
0.070
Why?
Thoracic Injuries
1
2006
29
0.070
Why?
Peritoneal Neoplasms
2
1998
152
0.070
Why?
California
1
2006
134
0.070
Why?
History, 21st Century
2
2017
169
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.070
Why?
Esophagoplasty
1
2005
10
0.070
Why?
Anesthetics
1
2005
47
0.070
Why?
Radiotherapy Dosage
1
2006
485
0.070
Why?
Blood Loss, Surgical
1
2005
106
0.070
Why?
Risk
1
2006
667
0.070
Why?
Antigens, Neoplasm
1
2006
317
0.060
Why?
Adolescent
3
2021
8669
0.060
Why?
Incidence
2
2022
1540
0.060
Why?
Preoperative Care
1
2005
382
0.060
Why?
Proto-Oncogene Proteins c-ret
1
2022
18
0.060
Why?
Work-Life Balance
1
2022
6
0.060
Why?
Organ Preservation
1
2022
73
0.060
Why?
Smoking
1
2006
594
0.060
Why?
Asthma
1
2009
913
0.050
Why?
Hospital Mortality
1
2003
322
0.050
Why?
Leukocytes
1
2022
192
0.050
Why?
Transfection
3
2011
885
0.050
Why?
Cross Reactions
1
2021
110
0.050
Why?
Clinical Competence
2
2020
720
0.050
Why?
Oxygen
1
2006
706
0.050
Why?
Antigens, Viral
1
2021
145
0.050
Why?
Immunity, Humoral
1
2021
66
0.050
Why?
Child
2
2022
6544
0.050
Why?
Bioethics
1
2020
31
0.050
Why?
Epitopes
1
2021
253
0.050
Why?
Risk Management
1
2020
43
0.050
Why?
Etoposide
1
2020
192
0.050
Why?
Practice Guidelines as Topic
2
2018
1013
0.050
Why?
Bias
1
2020
125
0.050
Why?
Margins of Excision
1
2019
36
0.050
Why?
Medicare
1
2022
332
0.050
Why?
Survivors
1
2021
209
0.050
Why?
Asbestosis
2
1998
5
0.050
Why?
Phosphoproteins
1
2021
250
0.050
Why?
Interdisciplinary Communication
1
2020
124
0.050
Why?
Tissue Donors
1
2022
419
0.050
Why?
Living Donors
1
2022
309
0.040
Why?
Sputum
1
2018
31
0.040
Why?
Infection Control
1
2020
107
0.040
Why?
Tumor Virus Infections
1
1998
79
0.040
Why?
Electrocardiography
1
2021
466
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2018
122
0.040
Why?
Heart
1
2021
499
0.040
Why?
Oligonucleotides, Antisense
1
1998
68
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
1998
142
0.040
Why?
Self Report
1
2019
270
0.040
Why?
RNA, Ribosomal, 16S
1
2018
220
0.040
Why?
Pilot Projects
2
2012
795
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
142
0.040
Why?
RNA, Antisense
1
1996
16
0.040
Why?
Liver
1
2022
1187
0.040
Why?
Feasibility Studies
2
1996
725
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
10
0.040
Why?
Receptor, ErbB-2
1
2018
198
0.040
Why?
Sensitivity and Specificity
2
2012
1939
0.040
Why?
Comorbidity
1
2020
915
0.040
Why?
Protein-Tyrosine Kinases
1
2018
300
0.040
Why?
Proto-Oncogene Proteins c-met
1
2018
197
0.040
Why?
Anniversaries and Special Events
1
2016
14
0.040
Why?
B-Lymphocytes
1
2021
723
0.040
Why?
Papillomavirus Infections
1
1998
234
0.040
Why?
Heart Ventricles
1
2021
731
0.040
Why?
Chromosome Disorders
1
1995
113
0.040
Why?
Radiation Oncology
1
2017
121
0.030
Why?
National Institutes of Health (U.S.)
1
1995
104
0.030
Why?
Genes, Tumor Suppressor
1
1995
157
0.030
Why?
Clinical Trials, Phase II as Topic
1
1995
169
0.030
Why?
Base Sequence
2
1996
2313
0.030
Why?
Clinical Trials, Phase I as Topic
1
1995
147
0.030
Why?
History, 20th Century
1
2016
304
0.030
Why?
Proto-Oncogene Proteins
1
2018
646
0.030
Why?
Chromosome Aberrations
1
1995
381
0.030
Why?
Genetic Testing
1
2018
506
0.030
Why?
Molecular Sequence Data
2
1996
3026
0.030
Why?
Immunohistochemistry
1
2018
1713
0.030
Why?
DNA Damage
1
1995
350
0.030
Why?
Genetic Therapy
1
1995
334
0.030
Why?
Immunoenzyme Techniques
1
2013
299
0.030
Why?
Fluorescent Antibody Technique
1
2013
308
0.030
Why?
Pleural Effusion
1
2012
44
0.030
Why?
Pleural Effusion, Malignant
1
2012
14
0.030
Why?
Cricetinae
3
1998
559
0.030
Why?
Reactive Oxygen Species
1
1995
449
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
265
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
678
0.030
Why?
Fear
1
2012
67
0.030
Why?
Self Concept
1
2012
128
0.030
Why?
Recurrence
1
2014
1118
0.030
Why?
RNA, Small Interfering
1
2013
538
0.030
Why?
Thoracoscopes
1
2011
2
0.030
Why?
Surgical Staplers
1
2011
10
0.030
Why?
Radiography, Thoracic
1
2013
317
0.030
Why?
Taxoids
1
2011
128
0.030
Why?
Dissection
1
2011
42
0.030
Why?
Computer Graphics
1
2011
100
0.030
Why?
Motor Skills
1
2011
69
0.020
Why?
Community-Based Participatory Research
1
2010
35
0.020
Why?
Patient Positioning
1
2011
57
0.020
Why?
Carboplatin
1
2011
281
0.020
Why?
Kaplan-Meier Estimate
1
2012
842
0.020
Why?
Mediastinum
1
2010
46
0.020
Why?
Affect
1
2012
377
0.020
Why?
Multivariate Analysis
1
2012
961
0.020
Why?
Biopsy, Needle
1
2010
232
0.020
Why?
Down-Regulation
1
2011
497
0.020
Why?
Longitudinal Studies
1
2012
948
0.020
Why?
Depression
1
2012
421
0.020
Why?
Empyema
1
2008
9
0.020
Why?
Cells, Cultured
1
2013
2773
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1163
0.020
Why?
Plasmids
2
1998
279
0.020
Why?
Insulin-Like Growth Factor I
2
1998
114
0.020
Why?
Carbonic Anhydrase IX
1
2006
9
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Regression Analysis
1
2007
585
0.020
Why?
Lymphatic Diseases
1
2005
35
0.020
Why?
Tracheal Diseases
1
2005
12
0.020
Why?
Age Factors
1
2010
1778
0.020
Why?
Polymerase Chain Reaction
2
1998
922
0.020
Why?
Predictive Value of Tests
1
2010
1605
0.020
Why?
Animals
4
1998
25628
0.020
Why?
Reproducibility of Results
1
2010
2583
0.020
Why?
Lymphoma, Non-Hodgkin
1
2005
254
0.020
Why?
Disease Progression
1
2007
1435
0.010
Why?
Gene Expression Regulation, Viral
1
1998
90
0.010
Why?
Virus Replication
1
1998
309
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
110
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
27
0.010
Why?
Sarcoma, Ewing
1
1996
42
0.010
Why?
Cardiac Output
1
1996
151
0.010
Why?
Hyperthermia, Induced
1
1996
53
0.010
Why?
Safety
1
1996
152
0.010
Why?
Cell Transformation, Neoplastic
1
1998
406
0.010
Why?
Cell Division
1
1996
689
0.010
Why?
Sarcoma
1
1996
205
0.010
Why?
Pulmonary Artery
1
1996
285
0.010
Why?
Remission Induction
1
1996
705
0.010
Why?
Interferon-gamma
1
1996
437
0.010
Why?
Melanoma
1
1996
431
0.010
Why?
Carcinoma, Renal Cell
1
1996
402
0.010
Why?
Transcription, Genetic
1
1996
1116
0.010
Why?
Blood Pressure
1
1996
1107
0.010
Why?
Rats
1
1996
3904
0.010
Why?
Donington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (404)
Explore
_
Co-Authors (38)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_